Organigram Global and Sanity Group Announce Successful Closing of Acquisition

Evaluation Report on Second Anniversary of German Cannabis Act: Sanity Group Calls for Evidence-Based Regulation

Sanity Group and Curaleaf Laboratories Announce Partnership to Advance Medical Cannabis Innovation in the UK

Cannabis legalization in Germany – Statement on the revised cornerstone paper

Endosane Pharmaceuticals agrees to Licence Agreement with PreveCeutical Medical thereby Securing Exclusive Rights to Innovative Technology

German Cannabis company Sanity Group announces $37.6 Million Series B funding round

Portugal, South Africa and Canada: Sanity Group strengthens and diversifies its global partner network

Sanity Group has expanded its management team

Vayamed Cannakits®: Innovative cannabis formulation kits enable new forms of application for an expanded therapy spectrum – experienced therapists sought for clinical support survey

Sanity Group at the hemp fair Mary Jane and ICBC Berlin 2022